FDA
Named in 368 articles by 133 newsrooms, in 199 stories, on 14 of the last 14 days.
ARTICLES PER DAY
STORIES THAT NAME FDA
- 2 OctSierra Nevada Raw Milk Cheese Recalled After E. Coli Outbreak
- 29 SepFDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled
- 28 SepFDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled
- 27 SepMeta expands smart-glasses lineup while addressing privacy concerns
- 27 SepFDA nominee Heidi Overton questioned on abortion medication, birth control and vaccines
- 27 SepFDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled
- 26 SepMeta expands smart-glasses lineup while addressing privacy concerns
- 26 SepFDA nominee Heidi Overton questioned on abortion medication, birth control and vaccines
- 26 SepFDA advisers endorse Grail’s multi-cancer blood test
- 26 SepFDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled
- 26 SepKyverna Reports One-Year Autoimmune CAR-T Data, Targets BLA Completion
- 25 SepMeta expands AI hardware lineup with camera-free glasses, Charm gadget and new software
- 25 SepFDA nominee Heidi Overton questioned on abortion medication, birth control and vaccines
- 25 SepFDA advisers endorse Grail’s multi-cancer blood test
- 25 SepFDA Warns Empower Pharmacy Over Compounded GLP-1 Drugs
- 25 SepFDA Raises Thyroid Drug Recall to Highest Risk Level as Blood Pressure Medicine Is Recalled
- 25 SepKyverna Reports One-Year Autoimmune CAR-T Data, Targets BLA Completion
- 24 SepMeta unveils camera-free AI glasses and expands smart-glasses software
- 24 SepFDA nominee Heidi Overton backs vaccine safety at Senate hearing
- 24 SepFDA advisers endorse Grail’s multi-cancer blood test
- 24 SepGLP-1 Use and Compounding Draw Growing Scrutiny
- 24 SepFDA Elevates Thyroid Medication Recall to Highest Risk Level
- 23 SepFDA Panel to Decide on Approval of Grail's Multi-Cancer Blood Test
A count of which stories named this name, found by a language model trained to spot names and joined to one spelling. It records who was written about, and with whom; it does not say why.